A detailed history of Pensionmark Financial Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Pensionmark Financial Group, LLC holds 33,671 shares of NVS stock, worth $3.31 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
33,671
Previous 261,369 87.12%
Holding current value
$3.31 Million
Previous $30.1 Million 87.12%
% of portfolio
0.13%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

SELL
$106.13 - $120.89 $24.2 Million - $27.5 Million
-227,698 Reduced 87.12%
33,671 $3.87 Million
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $27.7 Million - $31.6 Million
261,369 New
261,369 $30.1 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Pensionmark Financial Group, LLC Portfolio

Follow Pensionmark Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionmark Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pensionmark Financial Group, LLC with notifications on news.